{"id":"https://openalex.org/W1992367796","doi":"https://doi.org/10.3109/10428199809057584","title":"Analogues of Pyridoxal Isonicotinoyl Hydrazone (PIH) as Potential Iron Chelators for the Treatment of Neoplasia","display_name":"Analogues of Pyridoxal Isonicotinoyl Hydrazone (PIH) as Potential Iron Chelators for the Treatment of Neoplasia","alternate_titles":[],"publication_year":1998,"publication_date":"1998-01-01","ids":{"openalex":"https://openalex.org/W1992367796","doi":"https://doi.org/10.3109/10428199809057584","mag":"1992367796","pmid":"https://pubmed.ncbi.nlm.nih.gov/9720714"},"language":"en","primary_location":{"id":"doi:10.3109/10428199809057584","doi":"https://doi.org/10.3109/10428199809057584","is_oa":false,"landing_page_url":"https://doi.org/10.3109/10428199809057584","pdf_url":null,"source":{"id":"https://openalex.org/S27064115","display_name":"Leukemia & lymphoma/Leukemia and lymphoma","issn_l":"1026-8022","issn":["1026-8022","1029-2403","1042-8194"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia &amp; Lymphoma","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1992367796"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061763563","display_name":"Des Raymond Richardson","orcid":"https://orcid.org/0000-0002-5506-3274","observed_orcids":["https://orcid.org/0000-0002-5506-3274","https://orcid.org/0000-0003-0960-6415"]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]},{"id":"https://openalex.org/I2799393793","display_name":"Royal Brisbane and Women's Hospital","ror":"https://ror.org/05p52kj31","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I1302211766","https://openalex.org/I2799393793","https://openalex.org/I2801244131"]}],"countries":["AU"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Des R. Richardson","raw_affiliation_strings":["Department of Medicine, Royal Brisbane Hospital, Queensland, Australia. D. Richardson@medicine.herston.uq.edu.au","Department of Medicine, Clinical Sciences Building, Royal Brisbane Hospital, Brisbane, Queensland, 4029, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Royal Brisbane Hospital, Queensland, Australia. D. Richardson@medicine.herston.uq.edu.au","institution_ids":["https://openalex.org/I165143802"]},{"raw_affiliation_string":"Department of Medicine, Clinical Sciences Building, Royal Brisbane Hospital, Brisbane, Queensland, 4029, Australia","institution_ids":["https://openalex.org/I2799393793"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5061763563"],"corresponding_institution_ids":["https://openalex.org/I165143802","https://openalex.org/I2799393793"],"apc_list":null,"apc_paid":null,"fwci":0.7655,"has_fulltext":false,"cited_by_count":28,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.57906977,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":"31","issue":"1-2","first_page":"47","last_page":"60"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10452","display_name":"Iron Metabolism and Disorders","score":0.5976999998092651,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10452","display_name":"Iron Metabolism and Disorders","score":0.5976999998092651,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10163","display_name":"Metal complexes synthesis and properties","score":0.2483000010251999,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.03350000083446503,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pyridoxal-isonicotinoyl-hydrazone","display_name":"pyridoxal isonicotinoyl hydrazone","score":0.9890000224113464},{"id":"https://openalex.org/keywords/iron-chelators","display_name":"iron chelators","score":0.8849999904632568},{"id":"https://openalex.org/keywords/deferoxamine","display_name":"deferoxamine","score":0.8149999976158142},{"id":"https://openalex.org/keywords/antiproliferative-agents","display_name":"antiproliferative agents","score":0.8460000157356262},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.7950000166893005},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.7459999918937683},{"id":"https://openalex.org/keywords/leukemia","display_name":"leukemia","score":0.5170000195503235},{"id":"https://openalex.org/keywords/neuroblastoma","display_name":"neuroblastoma","score":0.8989999890327454},{"id":"https://openalex.org/keywords/iron-mobilization","display_name":"iron mobilization","score":0.44699999690055847}],"concepts":[{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6948126554489136},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.669131338596344},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.6038839221000671},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5724132657051086},{"id":"https://openalex.org/C2780349576","wikidata":"https://www.wikidata.org/wiki/Q416007","display_name":"Hydrazone","level":2,"score":0.5668033957481384},{"id":"https://openalex.org/C2776232574","wikidata":"https://www.wikidata.org/wiki/Q415571","display_name":"Bleomycin","level":3,"score":0.552868127822876},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4415208697319031},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.4114496111869812},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.2624683976173401},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.25190842151641846},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.22627165913581848},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.18618592619895935},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1603398621082306},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001692","descriptor_name":"Biological Transport","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D002352","descriptor_name":"Carrier Proteins","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D002455","descriptor_name":"Cell Division","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007502","descriptor_name":"Iron Chelating Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007538","descriptor_name":"Isoniazid","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D007538","descriptor_name":"Isoniazid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008565","descriptor_name":"Membrane Proteins","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011730","descriptor_name":"Pyridoxal","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D011730","descriptor_name":"Pyridoxal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.3109/10428199809057584","doi":"https://doi.org/10.3109/10428199809057584","is_oa":false,"landing_page_url":"https://doi.org/10.3109/10428199809057584","pdf_url":null,"source":{"id":"https://openalex.org/S27064115","display_name":"Leukemia & lymphoma/Leukemia and lymphoma","issn_l":"1026-8022","issn":["1026-8022","1029-2403","1042-8194"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia &amp; Lymphoma","raw_type":"journal-article"},{"id":"pmid:9720714","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9720714","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia & lymphoma","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320324195","display_name":"Medical Research Council Canada","ror":"https://ror.org/01gavpb45"},{"id":"https://openalex.org/F4320334705","display_name":"National Health and Medical Research Council","ror":"https://ror.org/011kf5r70"},{"id":"https://openalex.org/F4320334737","display_name":"National Medical Research Council","ror":"https://ror.org/04x3cxs03"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":73,"referenced_works":["https://openalex.org/W34816746","https://openalex.org/W153121858","https://openalex.org/W157133164","https://openalex.org/W334184796","https://openalex.org/W1497514444","https://openalex.org/W1502461041","https://openalex.org/W1526693931","https://openalex.org/W1564880933","https://openalex.org/W1568628619","https://openalex.org/W1575773639","https://openalex.org/W1871616831","https://openalex.org/W1967102030","https://openalex.org/W1968461095","https://openalex.org/W1968616621","https://openalex.org/W1968853836","https://openalex.org/W1970518172","https://openalex.org/W1982129404","https://openalex.org/W1983790993","https://openalex.org/W1992125101","https://openalex.org/W1992895997","https://openalex.org/W1995087031","https://openalex.org/W2006358233","https://openalex.org/W2008667004","https://openalex.org/W2024023157","https://openalex.org/W2025177304","https://openalex.org/W2025812024","https://openalex.org/W2025984741","https://openalex.org/W2034409947","https://openalex.org/W2035152288","https://openalex.org/W2035763080","https://openalex.org/W2043701906","https://openalex.org/W2051983330","https://openalex.org/W2054170541","https://openalex.org/W2054662394","https://openalex.org/W2059502417","https://openalex.org/W2060531233","https://openalex.org/W2067900214","https://openalex.org/W2073915702","https://openalex.org/W2080711791","https://openalex.org/W2081610483","https://openalex.org/W2082806735","https://openalex.org/W2084072384","https://openalex.org/W2084429638","https://openalex.org/W2086567353","https://openalex.org/W2087487456","https://openalex.org/W2088017190","https://openalex.org/W2089758217","https://openalex.org/W2092448093","https://openalex.org/W2092960333","https://openalex.org/W2096804213","https://openalex.org/W2097878215","https://openalex.org/W2112084291","https://openalex.org/W2116611374","https://openalex.org/W2118234018","https://openalex.org/W2119272726","https://openalex.org/W2119397834","https://openalex.org/W2122899892","https://openalex.org/W2124912754","https://openalex.org/W2138655599","https://openalex.org/W2143656505","https://openalex.org/W2146449631","https://openalex.org/W2159401034","https://openalex.org/W2159574733","https://openalex.org/W2170247657","https://openalex.org/W2213843327","https://openalex.org/W2339241266","https://openalex.org/W2346520058","https://openalex.org/W2400973399","https://openalex.org/W2410002027","https://openalex.org/W2414256411","https://openalex.org/W2417365885","https://openalex.org/W2465921122","https://openalex.org/W2610235419"],"related_works":["https://openalex.org/W1502461041","https://openalex.org/W2002176182","https://openalex.org/W34816746","https://openalex.org/W2089027621","https://openalex.org/W116663061","https://openalex.org/W1995087031","https://openalex.org/W2065071495","https://openalex.org/W2891998879","https://openalex.org/W2034409947"],"abstract_inverted_index":{"Cancer":[0],"cells":[1],"have":[2,33,127],"a":[3,12,16,61,109,122,185],"high":[4,68,113,141],"requirement":[5],"for":[6,72,130],"iron":[7],"(Fe)":[8],"as":[9,108,196,214],"it":[10],"plays":[11],"crucial":[13],"role":[14,174],"in":[15,28,31,39,147,177,202],"variety":[17],"of":[18,50,63,91,124,137,152,175,187],"metabolic":[19],"processes":[20],"including":[21,53,66],"energy":[22],"production":[23],"and":[24,30,55,80,168],"DNA":[25],"synthesis.":[26],"Studies":[27],"vitro":[29],"vivo":[32,203],"demonstrated":[34],"that":[35,111],"the":[36,48,70,89,164,173,188,193],"Fe":[37,94,99,117,176,206],"chelator":[38],"current":[40],"clinical":[41],"use,":[42],"desferrioxamine":[43],"(DFO),":[44],"can":[45],"effectively":[46],"inhibit":[47],"growth":[49,146],"some":[51,151],"neoplasms,":[52],"leukemia":[54],"neuroblastoma.":[56],"Unfortunately,":[57],"DFO":[58],"suffers":[59],"from":[60,118,158],"number":[62],"serious":[64],"disadvantages,":[65],"its":[67,81],"cost,":[69],"need":[71],"prolonged":[73],"subcutaneous":[74],"infusion":[75],"(12-24":[76],"h/day,":[77],"5-6":[78],"nights/week),":[79],"poor":[82],"intestinal":[83],"absorption":[84],"precluding":[85],"oral":[86],"administration.":[87],"Hence,":[88],"development":[90],"more":[92],"effective":[93,197],"chelators":[95,207],"is":[96],"necessary.":[97],"The":[98],"chelator,":[100],"pyridoxal":[101],"isonicotinoyl":[102],"hydrazone":[103],"(PIH),":[104],"was":[105],"initially":[106],"identified":[107],"ligand":[110],"showed":[112,160],"activity":[114,142,162],"at":[115,143],"mobilizing":[116],"cells.":[119],"More":[120],"recently,":[121],"range":[123],"PIH":[125,194],"analogues":[126,195],"been":[128],"examined":[129,182],"their":[131,212],"anti-proliferative":[132,198],"effect,":[133],"with":[134,204],"several":[135],"classes":[136],"these":[138,153,205],"compounds":[139],"showing":[140],"inhibiting":[144],"tumor":[145],"vitro.":[148],"In":[149,170],"fact,":[150],"hydrazones,":[154],"particularly":[155],"those":[156],"derived":[157],"2-hydroxy-1-naphthylaldehyde,":[159],"comparable":[161],"to":[163,210],"cytotoxic":[165],"drugs":[166],"cis-platin":[167],"bleomycin.":[169],"this":[171],"review":[172],"cellular":[178],"proliferation":[179],"will":[180],"be":[181],"followed":[183],"by":[184],"description":[186],"most":[189],"recent":[190],"studies":[191,201],"using":[192],"agents.":[199,216],"Further":[200],"are":[208],"essential":[209],"determine":[211],"potential":[213],"chemotherapeutic":[215]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1992367796","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
